FDA approves first oral anemia drug for renal patients on dialysis
By
Alicia Lasek
Feb 02, 2023
The agency has approved Jesduvroq tablets (daprodustat), the first oral treatment for kidney disease-related anemia in adults who have received dialysis for four months or more.